Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder Syndrome

NCT01824420 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

129

Enrollment

OTHER

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: Detrusitol 4mg QD and Oxybutynin ER 5mg QD
DRUG: Detrusitol 4mg QD

Sponsor

Buddhist Tzu Chi General Hospital